Company - Corporate Actions - Earnings
Endava plc (DAVA) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $0.29The estimated revenue is $257630000
...
September 19, 2024 DAVA 0.29%
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 19, 2024 KZIA 8.17%
Galapagos NV (GLPG) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The annoucened EPS was $0.14The estimated revenue...
September 19, 2024 GLPG 2.31%
Can-Fite Biopharma Ltd (CANF) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.36The estimated revenue is $100000
...
September 19, 2024 CANF -0.96%
X.T.L. Biopharmaceuticals Ltd. (XTLB) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 19, 2024 XTLB 2.11%
iHuman Inc (IH) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $34604200
...
September 18, 2024 XTLB 2.11%
Boqii Holding Limited (BQ) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $44260600
...
September 18, 2024 BQ 0.99%
Genfit (GNFT) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 18, 2024 GNFT -0.18%
Galapagos NV (GLPG) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The estimated revenue is $70050000
...
September 18, 2024 GLPG 2.31%
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 18, 2024 KZIA 8.17%